Evaluation of Safety and Efficacy of Shorttime TNI Treatment in Patients With COPD

NCT01686893 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2012-09-19

No results posted yet for this study

Summary

Evaluation of Safety and Efficacy of Shorttime TNI Treatment in Patients with COPD Acute testing of oxygen demand using TNI vs. standard oxygen application in stable COPD patients An investigator-initiated, prospective, controlled, multicenter study

Conditions

  • Oxygen Inhalation Therapy

Interventions

DEVICE

Nasal oxygen insufflation with a TNI 20 oxy device

Nasal oxygen insufflation with a TNI 20 oxy device

DEVICE

Standard Nasal Insufflation of oxygen

Standard Nasal Insufflation of oxygen

Sponsors & Collaborators

  • Medical University Innsbruck

    lead OTHER

Principal Investigators

  • Christian M Kaehler, MD · Pneumology, Medical University Innsbruck

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2013-02-28
Completion
2013-03-31

Countries

  • Austria
  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01686893 on ClinicalTrials.gov